Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Pfizer Venture Investments
AddedFeb 13, 2024
UpdatedJul 11, 2026
Pfizer Venture Investments

Pfizer Venture Investments

Operating

Pfizer Venture Investments: A strategic life science VC, investing in transformative medicines and technologies.

Location
New York City, NY, US
Founded
2004
Firm
Compare
Portfolio
Employees
Website

Pfizer Venture Investments focuses on life science investments in areas of strategic interest to Pfizer. The firm targets emerging companies developing transformative medicines and technologies that could enhance Pfizer's pipeline and shape the future of the industry. Investments typically range from Series A to Series C rounds, with occasional participation in later stages.

Notable portfolio companies include Kymera Therapeutics, Nimbus Therapeutics, and SpringWorks Therapeutics. Pfizer Ventures actively supports its portfolio companies, leveraging Pfizer's extensive resources and expertise in drug discovery, clinical development, and commercialization. The firm aims to remain at the forefront of life science advances, identifying and investing in innovative companies with the potential to drive significant advancements in healthcare.

Pfizer Venture Investments - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments87
Current Portfolio Count48
Total Portfolio Exits3

Top Investment Stages

Series A30 (37.0%)
Series B27 (33.3%)
Series C12 (14.8%)
Series Unknown11 (13.6%)
Late Stage Private1 (1.2%)

Stage Mix

Series A 37%Series B 33%Series C 15%Series Unknown 14%Late Stage Private 1%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Flare Therapeutics logo

Flare Therapeutics

Oblenio Bio logo

Oblenio Bio

RefleXion Medical logo

RefleXion Medical

ReCode Therapeutics logo

ReCode Therapeutics

Nimbus Therapeutics logo

Nimbus Therapeutics

Crossbow Therapeutics logo

Crossbow Therapeutics

Mozart Therapeutics logo

Mozart Therapeutics

Mediar Therapeutics logo

Mediar Therapeutics

Ribon Therapeutics logo

Ribon Therapeutics

Jnana Therapeutics logo

Jnana Therapeutics

Oxford Sciences Innovation logo

Oxford Sciences Innovation

Capstan Therapeutics logo

Capstan Therapeutics

Autobahn Therapeutics logo

Autobahn Therapeutics

MindImmune Therapeutics logo

MindImmune Therapeutics

DEM Biopharma logo

DEM Biopharma

Triana Biomedicines logo

Triana Biomedicines

TRex Bio logo

TRex Bio

Arkuda Therapeutics logo

Arkuda Therapeutics

Kestrel Therapeutics logo

Kestrel Therapeutics

Parthenon Therapeutics logo

Parthenon Therapeutics

Strata Oncology logo

Strata Oncology

Interius BioTherapeutics logo

Interius BioTherapeutics

Resilience logo

Resilience

Palleon Pharmaceuticals logo

Palleon Pharmaceuticals

Bolt Biotherapeutics logo

Bolt Biotherapeutics

Pfizer Venture Investments - Similar Investment Firms

Flagship Pioneering logo

Flagship Pioneering

Nest.Bio Venture logo

Nest.Bio Venture

nest.bio

McKesson Ventures logo

McKesson Ventures

AbbVie Biotech Ventures logo

AbbVie Biotech Ventures

abbvie.com

Vida Ventures logo

Vida Ventures

vidaventures.com

Chiesi Ventures logo

Chiesi Ventures

chiesiventures.com

Peregrine Ventures logo

Peregrine Ventures

peregrinevc.com

Pontifax logo

Pontifax

pontifax.com

Versant Ventures logo

Versant Ventures

Nan Fung Life Sciences logo

Nan Fung Life Sciences

PFM Health Sciences logo

PFM Health Sciences

Bioventures Investors logo

Bioventures Investors

Pathway to Cures logo

Pathway to Cures

pathwaytocures.org

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

Pivotal bioVenture Partners logo

Pivotal bioVenture Partners

Pfizer Venture Investments - Classification

Also Known As
  • Pfizer Venture Investments LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end